Overview We are a clinical-stage biopharmaceutical company advancing therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. We are driven by innovative science to develop novel and transformative drug therapies to treat cancer. Our mission is to advance our portfolio of innovative therapeutics ...
Q2 FY2026 — expected 2026-09-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-31 | 2025-12-31 | 0001493152-26-014159 | EDGAR | 109K words |
| 2025-04-15 | 2024-12-31 | 0001641172-25-004920 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-14 | 2025-09-30 | 0001493152-25-023276 | EDGAR | 19K words |
| 2025-08-12 | 2025-06-30 | 0001641172-25-023167 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001641172-25-010089 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001493152-24-045671 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-22 | 0001493152-26-034185 | EDGAR | — |
| 2026-07-15 | 0001493152-26-033289 | EDGAR | — |
| 2026-03-02 | 0001493152-26-008435 | EDGAR | 1K words |
| 2026-02-26 | 0001493152-26-008116 | EDGAR | — |
| 2025-10-15 | 0001493152-25-018145 | EDGAR | — |
| 2025-10-07 | 0001493152-25-017208 | EDGAR | — |
| 2025-09-18 | 0001493152-25-013975 | EDGAR | — |
| 2025-09-11 | 0001493152-25-013040 | EDGAR | — |
| 2025-09-03 | 0001641172-25-026316 | EDGAR | — |
| 2025-07-15 | 0001641172-25-019645 | EDGAR | — |
47 total filings indexed. 31 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001962011 |
| Ticker | KAPA |
| Exchange | NYSE |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.kairospharma.com |
| Listed | 2024-09-16 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/KAPA (~200 tokens, structured JSON with cryptographic provenance)